DNA hypomethylation and ovarian cancer biology

Cancer Research
Martin WidschwendterM Ehrlich

Abstract

Hypomethylation of some portions of the genome and hypermethylation of others are very frequent in human cancer. The hypomethylation often involves satellite 2 (Sat2) DNA in the juxtacentromeric (centromere-adjacent) region of chromosome 1. In this study, we analyzed methylation in centromeric and juxtacentromeric satellite DNA in 115 ovarian cancers, 26 non-neoplastic ovarian specimens, and various normal somatic tissue standards. We found that hypomethylation of both types of satellite DNA in ovarian samples increased significantly from non-neoplastic toward cancer tissue. Furthermore, strong hypomethylation was significantly more prevalent in tumors of advanced stage or high grade. Importantly, extensive hypomethylation of Sat2 DNA in chromosome 1 was a highly significant marker of poor prognosis (relative risk for relapse, 4.1, and death, 9.4) and more informative than tumor grade or stage. Also, comparing methylation of satellite DNA and 15 5' gene regions, which are often hypermethylated in cancer or implicated in ovarian carcinogenesis, we generally found no positive or negative association between methylation changes in satellite DNA and in the gene regions. However, hypermethylation at two loci, CDH13 (at 16q24) and RN...Continue Reading

References

Feb 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C SessaF Cavalli
Dec 1, 1984·Carcinogenesis·B I CarrA Riggs
Oct 11, 1983·Nucleic Acids Research·M A Gama-SosaM Ehrlich
Jun 1, 1993·Human Molecular Genetics·M JeanpierreE Viegas-Pequignot
Apr 1, 1997·Nature Genetics·F MitelmanB Johansson
Oct 23, 1997·Mutation Research·W JiM Ehrlich
Aug 26, 1998·International Journal of Cancer. Journal International Du Cancer·A NarayanM Ehrlich
Sep 16, 1998·Human Genetics·M SatoA Horii
Sep 17, 1998·Nature·R Z ChenR Jaenisch
Jan 1, 1999·Nature·C LengauerB Vogelstein
Apr 14, 1999·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Feb 22, 2000·British Journal of Cancer·P S YanT H Huang
Mar 29, 2000·Nucleic Acids Research·C A EadsP W Laird
Jul 7, 2000·Seminars in Surgical Oncology·C H Holschneider, J S Berek
Jul 15, 2000·Cytogenetics and Cell Genetics·C M Tuck-MullerM Ehrlich
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·J B WelshG M Hampton
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·A P Feinberg
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·J H YoonG P Pfeifer
Oct 30, 2001·Behavioural Brain Research·Y BenjaminiI Golani
Apr 24, 2002·Oncogene·Rosaria A M ScelfoMassimo Negrini
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Aug 3, 2002·Oncogene·Melanie Ehrlich
Aug 31, 2002·Genes, Chromosomes & Cancer·Wolfgang A SchulzTapio Visakorpi
Sep 21, 2002·Oncogene·Melanie EhrlichPeter W Laird
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Feb 28, 2003·Cancer Genetics and Cytogenetics·Melanie EhrlichJeffrey Sawyer
Apr 19, 2003·Science·Amir EdenRudolf Jaenisch
Apr 19, 2003·Science·François GaudetRudolf Jaenisch
Jul 25, 2003·Expert Review of Molecular Diagnostics·Hannes M Müller, Martin Widschwendter

❮ Previous
Next ❯

Citations

Jan 27, 2010·Journal of Mammary Gland Biology and Neoplasia·Jürgen Veeck, Manel Esteller
May 15, 2013·Molecular Biology Reports·Adrianna MostowskaPaweł P Jagodzinski
Jan 17, 2012·Cancer Letters·Brian S Gloss, Goli Samimi
Sep 2, 2005·Nature Reviews. Genetics·Keith D Robertson
Dec 6, 2005·Nucleic Acids Research·Daniel J WeisenbergerPeter W Laird
May 4, 2010·Anti-cancer Drugs·Katarina Sebova, Ivana Fridrichova
Feb 19, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kanokwan IramaneeratApiwat Mutirangura
Mar 12, 2010·Genome Research·Andrew E TeschendorffMartin Widschwendter
Oct 20, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J PattamadilokA Mutirangura
Jun 17, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Michèle J Hoffmann, Wolfgang A Schulz
Aug 1, 2006·Journal of Biomedicine & Biotechnology·Wolfgang A Schulz
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anna Woloszynska-ReadAdam R Karpf
Feb 8, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anna Woloszynska-ReadAdam R Karpf
Aug 25, 2007·The Journal of Clinical Investigation·Diego F CalvisiSnorri S Thorgeirsson
Jun 8, 2010·BMC Bioinformatics·Leandro A LossBahram Parvin
Jun 8, 2013·EURASIP Journal on Bioinformatics & Systems Biology·Yihua LiuPeng Qiu
May 26, 2006·Orphanet Journal of Rare Diseases·Melanie EhrlichCorry Weemaes
Jul 4, 2009·Endocrinology·Curt BalchKenneth P Nephew
Feb 1, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David Rodenhiser, Mellissa Mann
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Magdalena MedrzyckiYuhong Fan
Dec 4, 2012·International Journal of Molecular Sciences·Vladimir KashubaEugene Zabarovsky
May 14, 2014·Molecular Medicine Reports·Ourania KoukouraStavros Sifakis
Mar 29, 2008·Pharmacogenomics·Emily A VucicWan L Lam
Apr 1, 2010·Epigenomics·Jason P RossPeter L Molloy
May 25, 2010·Epigenomics·Melanie Ehrlich
Aug 13, 2010·Biomarkers in Medicine·Leonel Maldonado, Mohammad Obaidul Hoque
Jul 21, 2005·Nutrition Reviews·Dale C McCabe, Marie A Caudill
Mar 28, 2009·Cellular and Molecular Life Sciences : CMLS·Igor P Pogribny, Frederick A Beland
Dec 18, 2004·Critical Reviews in Clinical Laboratory Sciences·Mukesh VermaSudhir Srivastava
Sep 6, 2007·Leukemia & Lymphoma·Jane E Kihslinger, Lucy A Godley
Oct 10, 2014·International Journal of Molecular Sciences·Morris M H HsuCheng-I Lee
Mar 14, 2013·Expert Opinion on Medical Diagnostics·Jonathan G BijronPaul J van Diest
Mar 16, 2011·FEBS Letters·Marie E Maradeo, Paul Cairns
Sep 25, 2014·Breast Cancer Research : BCR·Laura Barrio-RealMarcelo G Kazanietz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.